Symbols

YCBD

cbdMD·AMEX

--(--)

YCBD fundamentals

YCBD Q1 2026 Earnings

cbdMD (YCBD) released its earnings on Feb 17, 2026: revenue was 5.02M (YoY -1.89%), beat estimates; EPS was -0.04 (YoY +97.73%), beat estimates.

Revenue / YoY

5.02M

-1.89%

EPS / YoY

-0.04

+97.73%

Report date

Feb 17, 2026

YCBD Earnings Call Summary for Q1,2026

Revenue Growth: 12% sequential increase to $5 million, driven by DTC sales (72%) and wholesale growth (17% YoY).
Strategic Acquisition: Bluebird Botanicals adds IP, regulatory strength, and customer base, with integration focused on supply chain and marketing.
Financial Strength: $3.4 million cash, $5.4 million working capital, and $36,000 EBITDA loss, up from prior quarters.
Regulatory Focus: Advocating for HEMP Act to counter restrictive hemp legislation, positioning for Medicare CBD pilot program.

Earnings

EPS

Revenue

Revenue & Expenses

YCBD has released its 2026 Q1 earnings report, with revenue of 5.02M, reflecting a YoY change of -1.89%, and net profit of -283.13K, showing a YoY change of -1975.66%. The Sankey diagram below clearly presents YCBD's revenue sources and cost distribution.

Key Indicators

cbdMD (YCBD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

cbdMD (YCBD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

cbdMD (YCBD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

cbdMD (YCBD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown